KK
RVMD icon

KLP Kapitalforvaltning’s Revolution Medicines RVMD Stock Holding History

KLP Kapitalforvaltning’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Buy
67,100
+6,600
+11% +$964K 0.04% 351
2026
Q1 		$5.88M Buy
60,500
+30,496
+102% +$3.08M 0.02% 458
2025
Q4 		$2.39M Buy
30,004
+1,100
+4% +$72.1K 0.01% 651
2025
Q3 		$1.35M Hold
28,904
– – 0.01% 865
2025
Q2 		$1.06M Buy
28,904
+1,300
+5% +$49.9K ﹤0.01% 954
2025
Q1 		$976K Buy
27,604
+4,100
+17% +$166K ﹤0.01% 946
2024
Q4 		$1.03M Buy
+23,504
New +$1.19M ﹤0.01% 982

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

KLP Kapitalforvaltning's RVMD Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Revolution Medicines (RVMD) stake by 11% in Q2 2026, buying an estimated $964K and bringing the position to 67,100 shares worth $12.6M. The position accounts for 0.04% of the portfolio, ranked #351.

KLP Kapitalforvaltning first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • KLP Kapitalforvaltning held 67,100 shares of Revolution Medicines worth $12.6M as of Q2 2026.
  • KLP Kapitalforvaltning bought 6,600 Revolution Medicines shares in Q2 2026, an estimated $964K.
  • Revolution Medicines made up 0.04% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #351 holding.
  • KLP Kapitalforvaltning first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.